Zheng Quan Zhi Xing·2025-05-22 12:08Group 1 - The board of directors of Tonghua Dongbao Pharmaceutical Co., Ltd. held its 15th meeting of the 11th session on May 22, 2025, to discuss important company matters [1][2] - The board approved the proposal to transfer part of its shares in Xiamen Te Bao Biological Engineering Co., Ltd., holding 65,200,114 shares, which is 16.03% of Te Bao's total share capital [1] - The company decided to transfer 23,187,600 shares of Te Bao through a share transfer agreement with Tibet Trust Co., Ltd., representing a portion of its holdings [1][2] Group 2 - The share transfer does not constitute a related party transaction or a major asset restructuring as defined by relevant regulations [1] - The board also approved the proposal to convene the first temporary shareholders' meeting of 2025, with all votes in favor [2]